Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

DSIP Contraindications: Condition-by-Condition Comparison

Understanding DSIP contraindications requires distinguishing absolute exclusions (never appropriate for research use) from relative contraindications (may be acceptable with protocol modifications and enhanced monitoring). The following comparison table catego

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Understanding DSIP contraindications requires distinguishing absolute exclusions (never appropriate for research use) from relative contraindications (may be acceptable with protocol modifications and enhanced monitoring). The following comparison table categorizes specific medical conditions, defines the contraindication mechanism, and establishes whether the restriction is absolute or conditional.
  • Pregnancy / Lactation
  • No reproductive toxicology data; unknown fetal/infant exposure risk; CNS-active compound crosses blood-brain barrier
  • Absolute
  • Exclude unconditionally. Pregnancy test required for females of reproductive age
  • Concurrent CNS Depressants (benzodiazepines, opioids, Z-drugs, alcohol)
  • Additive GABAergic potentiation; prolonged cognitive impairment; unpredictable sedation depth
  • Absolute during active use; Relative after washout
  • Require 72-hour washout (short-acting) or 7–10 days (long-acting) with documented cessation
  • Active Autoimmune Disease (RA, SLE, MS, IBD)
  • Immunomodulatory effects unpredictable in dysregulated immune systems; potential disease exacerbation
  • Relative
  • Require rheumatology/immunology clearance, baseline markers, enhanced monitoring protocol
  • Untreated Adrenal Insufficiency or Cushing's Syndrome
  • HPA axis suppression (30–40% ACTH reduction); risk of adrenal crisis or cortisol instability
  • Absolute if untreated; Relative if stable on replacement therapy
  • Require endocrinology clearance and documented stable hormone levels for 3+ months
  • Uncontrolled Seizure Disorders
  • Bidirectional effects on seizure threshold; unpredictable interaction with anticonvulsants
  • Absolute if uncontrolled; Relative if seizure-free 12+ months on stable medication
  • Require neurology clearance and seizure diary documentation
  • Major Depressive Disorder with Active Suicidal Ideation
  • Transient mood dysregulation during initial 48 hours; serotonin receptor modulation in mood-regulating brain regions
  • Absolute during acute phase; Relative in stable remission
  • Require psychiatric clearance, stable medication regimen 6+ months, no recent hospitalization
  • Severe Multiple Drug Allergies or Anaphylaxis History
  • Hypersensitivity risk to peptide synthesis byproducts despite purification
  • Require allergy consultation and consider pre-medication or alternative compound selection
  • Organ Transplant on Immunosuppression
  • NK cell activation may oppose anti-rejection therapy; no interaction data with tacrolimus, cyclosporine
  • Exclude unconditionally due to risk to graft survival